Dr. John Hsu is the 2010 winner of the Weinstein-Goldenson Medical Science Award. This award is presented annually to a clinician-scientist for outstanding contributions in medical research which enhance the lives of individuals with cerebral palsy and their families.
John Hsu, MD, F.A.C.S.
Dr. Hsu is an Emeritus Clinical Professor in the Department of Orthopedics, at the University of California, Keck School of Medicine. He is the attending orthopedic surgeon at the Muscle Disease Clinic, Rancho Los Amigos National Rehabilitation Hospital and at the Children’s Fracture Clinic at the Orthopedic Hospital in Los Angeles, CA. He is a member of the American Orthopedic Association, the American Academy of Orthopaedic Surgeons, the American College of Surgeons and the Pediatric Rehabilitation Association among others. Dr. Hsu has over 120 publications and written numerous book chapters in the field of orthopedic surgery interventions for neuromuscular disorders such as cerebral palsy and Duchenne muscular dystrophy. Dr. Hsu has had a long and distinguished career in caring for children and adults with cerebral palsy.
It was a major international honor for John Hsu, MD as he received the 2010 Weinstein-Goldenson Medical Science Award at the Transformational Technology Workshop held on September 2-4, 2010 in Downey, CA. The award was presented to longtime Rancho physician John Hsu, MD by Glenn Tringali, the CEO of the CPIRF, at the conference. Although Dr. Hsu retired nearly a decade ago, he still regularly assists Rancho’s Pediatrics patients.
“This puts an exclamation point on my career,” Dr. Hsu said. “I’m thankful to the CPIRF, but also to all my Rancho colleagues who have encouraged my research and work in the clinics and made my life so interesting and meaningful for all these years.”
Read more: The Downey Patriot – World leaders in health science gather at Rancho
Dr. Terrance Sanger is the 2010 winner of the Isabelle and Leonard H. Goldenson Technology and Rehabilitation Award. This award is presented annually to a scientist for outstanding contributions in the development and use of technology and rehabilitation methodologies that enhance the quality of life for individuals with cerebral palsy and other disabilities and their families. Dr. Sanger was presented with the award at the 2010 American Academy of Cerebral Palsy and Developmental Medicine Annual Conference in Washington, DC on September 24, 2010.
Terrance Sanger, MD, PhD
Dr. Sanger is Associate Professor of Biomedical Engineering, Neurology, and Biokinesiology departments and on the medical staff at the Children’s Hospital of Los Angeles, Department of Neurology. He graduated from Harvard Medical School Division of Health Sciences and Technology with a medical degree in 1993 and from the Massachusetts Institute of Technology with a doctorate in Electrical Engineering and Computer Science.
Dr. Sanger’s primary research goal is to understand and prevent adverse effects of childhood brain disorders on motor development. His major research areas in computational neurosciences and neural networks include the mathematical description of dystonia and abnormal human movement; mathematical models of abnormal basal ganglia function and neural networks of normal and disordered learning. His major clinical research areas include tools for quantification and diagnosis of dystonia in children, the role of botulinum toxin in the modification of learned motor patterns, and feedback retraining of multiple-muscle patterned movement. He is currently funded by the NIH to use high-speed programmable logic devices to simulate the development of long and short-latency reflexes and the evolution of spasticity and dystonia in children with early brain injury. He has had past research funding from NIH, CPIRF, the Lucile Packard Children’s Hospital, the Allergan Corporation, the Pfizer Pharmaceuticals Group and Elan Pharmaceuticals. He has published 52 papers in peer reviewed journals and has been invited to present at scientific meetings and conferences on well over 32 occasions.
Most treatments for cerebral palsy (CP) are initially directed toward children. What is not clearly established is the long- term effects of such treatments. Many appear helpful in the short term but prove to be disadvantageous in the long run. Selective dorsal rhizotomy (SDR) is a permanent, irreversible neurosurgical procedure for reducing spasticity in cerebral palsy. Parents contemplating SDR for their child would like assurance that that there will not be harmful complications from it as the child ages into adolescence and adulthood. We now have new evidence...
A lot of what you point out is astonishingly precise and that makes me wonder the reason why I had not looked at this with this light previously. Your piece really did switch the light on for me personally as far as this specific subject matter goes. But at this time there is actually just one factor I am not too cozy with so while I try to reconcile that with the actual core idea of the position, let me see exactly what all the rest of your subscribers have to say.Very well done.